Abstract

Furosemide 10-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2017 - Volume 21, Number 2

Page(s): 148

Download in electronic PDF format for $75

Abstract

A formulation for preparing Furosemide 10-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2017 Pg. 148	Furosemide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 321-322	Furosemide 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2019 Pg. 414-417	Stability of Furosemide 5 mg/mL in Polypropylene Syringes Author(s): van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
Jul/Aug 2009 Pg. 335	Dexamethasone and Furosemide Injection Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Mar/Apr 2012 Pg. 158	Furosemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 367-371	Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Author(s): Williams LaVonn A, Riley Kari
May/Jun 2020 Pg. 246-251	Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days Author(s): Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara
Nov/Dec 2017 Pg. 496	Spironolactone 5 mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 411	Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 320	Torsemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 522-526	Intravenous Physical Compatibility of Heparin Sodium and Furosemide Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Jan/Feb 2014 Pg. 61	Bumetanide 0.25-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 503	Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 453	Furosemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 40-45	Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Mar/Apr 2010 Pg. 157	Metolazone 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 45	Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Author(s): Allen Loyd V Jr